Journal of Endocrinological Investigation

, Volume 9, Issue 1, pp 21–25 | Cite as

Rapid changes in plasma androgens during insulin withdrawal in male Type 1 (insulin-dependent) diabetics

  • Sten Madsbad
  • C. Gluud
  • P. Bennett
  • T. Krarup


Plasma concentrations of testosterone, androstenedione and dihydrotestosterone were measured in 15 Typet (insulin-dependent) diabetics with (n = 8) and without (n = 7) B-cell function during 12 h of insulin withdrawal and compared with those of 8 normal subjects. Before insulin withdrawal no significant difference was found in androgen concentrations between the diabetic and the normal subjects. The normal diurnal profiles, with highest androgen concentrations in the morning before insulin withdrawal (08:00) and lowest concentrations at 20:00 h were maintained in the diabetics. However, testosterone and dihydrotestosterone concentrations were lower in the diabetics after 4 h of insulin withdrawal and remained so throughout the study. The concentrations of androstenedione were not significantly different between diabetics and normal subjects except after 4 h of insulin withdrawal. Despite the patients without B-cell function were more metabolically decompensated from after 4 h of insulin withdrawal compared with patients with B-cell function, no significant differences were found in androgen concentrations between the two groups although a tendency to lower concentrations were seen in the group without B-cell function.


Androgens type 1 diabetes residual B-cell function insulin withdrawal 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Buus Jensen S. Diabetic sexual dysfunction: A comparative study of 160 insulin treated men and women and an age-matched control group. Arch. Sex. Behav. 10: 493, 1981.CrossRefGoogle Scholar
  2. 2.
    Gluud C., Madsbad S., Krarup T., Bennet P. Plasma testosterone and androstenedione in insulin dependent patients at time of diagnosis and during the first year of insulin treatment. Acta Endocrinol. (Kbh.) 100: 406, 1982.Google Scholar
  3. 3.
    Vermeulen A. The androgens. In Gray C.H., James VHT. (Eds.), Hormones in blood. Academic Press, London, New York, San Francisco, Vol. 3, 1979, p. 356.Google Scholar
  4. 4.
    Meikle A.W., Stringham J.D., Wilson D.E., Dolman L.I. Plasma 5 α-reduced androgens in men and hirsute women: Role of adrenals and gonads. J. Clin. Endocrinol. Metab. 48: 969, 1979.PubMedCrossRefGoogle Scholar
  5. 5.
    Faber O.K., Binder C. C-peptide response to glucagon. A test for the residual Beta-cell function in diabetes mellitus. Diabetes 26: 605, 1977.PubMedCrossRefGoogle Scholar
  6. 6.
    Parker Jr. C.R., Ellegood J.O., Mahesh V.B. Methods for multiple steroid radioimmunoassay. J. Steroid Biochem. 6: 1, 1975.PubMedCrossRefGoogle Scholar
  7. 7.
    Faber O.K., Markussen J., Naithani V.K., Binder C. Production of antisera to synthetic benzyloxy-carbonyl-C-peptide of human proinsulin. Hoppe Seylers Z. Physiol. Chem. 357: 751, 1976.PubMedCrossRefGoogle Scholar
  8. 8.
    Kurtz A.B., Mustaffa B.E., Daggett P.R., Nabarro J.D.N. Effect of insulin antibodies on free and total plasma insulin. Lancet 2: 56, 1977.PubMedCrossRefGoogle Scholar
  9. 9.
    Berchtold P., Berger M., Cüppers H.J., Herrmann J., Nieschlag E., Rudorff K., Zimmermann H., Krüskemper H.L. Non-glucoregulatory hormones (T4, T3, rT3, TSH, testosterone) during physical exercise in juvenile-type diabetics. Horm. Metab. Res. 10: 269, 1978.PubMedCrossRefGoogle Scholar
  10. 10.
    Nakashima A., Koshiyama K., Kozumi T., Morden Y., Hamanaka Y., Kurachi K., Aono T., Muzutani S., Matsumato K. Effects of general anesthesia and severity of surgical stress on serum LH and testosterone in males. Acta Endocrinol. (Khb.) 78: 258, 1975.Google Scholar
  11. 11.
    Dolecek R., Adamkova M., Sotornikova T., Slosarcik K., Zavada M. Syndrome of afterburn peripheral endocrine gland involvement — very low plasma testosterone levels in burned male patients. Acta Chir. Plast. 21: 114, 1979.PubMedGoogle Scholar
  12. 12.
    Deslypere J.P., Vermeulen A. Leydig cell function in normal men: Effect of age, lifestyle, residence, diet, and activity. J. Clin. Endocrinol. Metab. 59: 955, 1984.PubMedCrossRefGoogle Scholar
  13. 13.
    Goussis O.S., Pardridge W.M., Judd H.L. Critical illness and low testosterone: Effects of human serum on testosterone transport into rat brain and liver. J. Clin. Endocrinol. Metab. 56: 710, 1983.PubMedCrossRefGoogle Scholar
  14. 14.
    Rubin A., Babbot D. Impotence and diabetes mellitus. J. Steroid Biochem. 168: 498, 1958.Google Scholar
  15. 15.
    Wagner G., Hilsted J., Jensen S.B. Diabetes mellitus and erectile failure. In: Wagner G., Green R. (Eds.), Impotence. Plenum Press, New York, 1981, p. 51.CrossRefGoogle Scholar
  16. 16.
    Kolodny R.C., Kahn C.B., Goldstein H.H., Barnett D.M. Sexual dysfunction in diabetic man. Diabetes 23: 306, 1974.PubMedGoogle Scholar
  17. 17.
    Schöffling K., Federlin K., Ditschunheit H., Pfeiffer E.F. Disorders of sexual function in male diabetics. Diabetes 12: 519, 1963.Google Scholar

Copyright information

© Italian Society of Endocrinology (SIE) 1986

Authors and Affiliations

  • Sten Madsbad
    • 1
  • C. Gluud
    • 2
  • P. Bennett
    • 3
  • T. Krarup
    • 1
  1. 1.Hvidφre HospitalKlampenborgDenmark
  2. 2.Department of Medicine, Division of Hepatology, Hvidovre HospitalUniversity of CopenhagenCopenhagenDenmark
  3. 3.Hormone DepartmentStatens SeruminstitutCopenhagenDenmark

Personalised recommendations